X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-10 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $230.36 | -1,000 | 90,864 | -1% | -$230,360 | ||||||
| M | 2025-03-10 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $45.02 | -12,806 | 305,846 | -4% | -$576,578 | |||||
2025-03-10 | DXCM | Dexcom Inc | Sylvain Jereme M | EVP, Chief Financal Officer | S - Sale | $73.83 | -7,000 | 135,482 | -5% | -$516,830 | ||||||
2025-03-07 | TNDM | Tandem Diabetes Care Inc | Kyrillos Jean-Claude | EVP, COO | P - Purchase | $18.12 | +10,538 | 10,538 | New | +$190,966 | ||||||
2025-03-10 | NXGL | Nexgel, Inc. | Henry Scott Robert | Dir | S - Sale | $2.87 | -3,000 | 138,053 | -2% | -$8,621 | ||||||
| D | 2025-03-10 | RMD | Resmed Inc | Ghoshal Kaushik | Chief Commercial Officer, SaaS | S - Sale+OE | $239.31 | -9,745 | 19,353 | -33% | -$2,332,096 | |||||
| D | 2025-03-07 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $229.20 | -8,009 | 457,562 | -2% | -$1,835,692 | |||||
2025-03-07 | CERS | Cerus Corp | Jensen Chrystal | GC | S - Sale | $1.50 | -27,457 | 832,318 | -3% | -$41,131 | ||||||
2025-03-07 | CERS | Cerus Corp | Jayaraman Vivek K | COO | S - Sale | $1.50 | -33,999 | 1,507,315 | -2% | -$50,931 | ||||||
2025-03-07 | CERS | Cerus Corp | Greenman William Mariner | Pres, CEO | S - Sale | $1.50 | -60,984 | 4,309,758 | -1% | -$91,354 | ||||||
2025-03-07 | CERS | Cerus Corp | Green Kevin Dennis | CFO | S - Sale | $1.50 | -31,148 | 935,754 | -3% | -$46,660 | ||||||
2025-03-07 | CERS | Cerus Corp | Benjamin Richard J | Chief Medical Officer | S - Sale | $1.50 | -26,139 | 734,799 | -3% | -$39,156 | ||||||
| D | 2025-03-06 | AORT | Artivion, Inc. | Mackin James P | Pres, CEO | S - Sale+OE | $24.77 | -88,439 | 865,283 | -9% | -$2,190,848 | |||||
2025-03-06 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $24.80 | -1,048 | 146,651 | -1% | -$25,995 | ||||||
2025-03-06 | AORT | Artivion, Inc. | Berry Lance A | EVP, CFO | S - Sale | $24.80 | -4,909 | 153,431 | -3% | -$121,764 | ||||||
2025-03-06 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale | $24.80 | -2,618 | 207,968 | -1% | -$64,939 | ||||||
2025-03-06 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $24.80 | -1,603 | 115,880 | -1% | -$39,761 | ||||||
2025-03-06 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $24.80 | -2,124 | 196,112 | -1% | -$52,685 | ||||||
2025-03-06 | PRCT | Procept Biorobotics Corp | Nouri Alaleh | EVP, CLO, CORP. SEC. | S - Sale | $61.31 | -3,641 | 61,789 | -6% | -$223,230 | ||||||
2025-03-06 | RCEL | Avita Medical, Inc. | McNamara Robert | Dir | P - Purchase | $8.30 | +11,000 | 56,749 | +24% | +$91,300 | ||||||
2025-03-06 | PRCT | Procept Biorobotics Corp | Shiblaq Hisham | EVP, Chief Comm. Officer | S - Sale | $61.31 | -3,588 | 63,380 | -5% | -$219,980 | ||||||
2025-03-06 | PRCT | Procept Biorobotics Corp | Waters Kevin | EVP, CFO | S - Sale | $61.31 | -3,662 | 108,724 | -3% | -$224,517 | ||||||
2025-03-06 | PRCT | Procept Biorobotics Corp | Zadno Reza | Pres, CEO | S - Sale | $61.31 | -15,916 | 178,545 | -8% | -$975,810 | ||||||
2025-03-06 | ATEC | Alphatec Holdings, Inc. | Sponsel David | EVP, Sales | S - Sale | $10.83 | -33,732 | 668,977 | -5% | -$365,318 | ||||||
2025-03-07 | ATEC | Alphatec Holdings, Inc. | Miles Patrick | CEO | S - Sale | $10.64 | -12,691 | 6,118,503 | 0% | -$135,032 | ||||||
| D | 2025-03-05 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale+OE | $283.59 | -61,600 | 853,958 | -7% | -$17,468,917 | |||||
| A | 2022-01-26 | ATAO | Altair International Corp. | Lovallo Leonard | Pres | S - Sale | $0.03 | -150,000 | 39,130,000 | 0% | -$4,605 | |||||
| A | 2022-01-26 | ATAO | Altair International Corp. | Lovallo Leonard | Pres | S - Sale | $0.03 | -150,000 | 39,130,000 | 0% | -$4,605 | |||||
2022-01-26 | ATAO | Altair International Corp. | Lovallo Leonard | Pres | S - Sale | $0.03 | -150,000 | 39,130,000 | 0% | -$4,605 | ||||||
2025-03-05 | ATRC | Atricure, Inc. | Prange Karen | Dir | S - Sale | $38.12 | -6,100 | 17,828 | -25% | -$232,532 | ||||||
| M | 2025-03-04 | FNA | Paragon 28, Inc. | Mvm Partners, LLC | 10% | S - Sale | $13.01 | -1,374,635 | 8,854,883 | -13% | -$17,880,070 | |||||
2025-03-05 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $227.71 | -2,000 | 75,218 | -3% | -$455,420 | ||||||
| D | 2025-03-05 | MMSI | Merit Medical Systems Inc | Lampropoulos Fred P | Pres, CEO | S - Sale+OE | $103.85 | -34,320 | 1,191,650 | -3% | -$3,564,069 | |||||
| D | 2025-03-05 | MMSI | Merit Medical Systems Inc | Parra Raul Jr. | CFO, Treasurer | S - Sale+OE | $103.58 | -5,361 | 26,971 | -17% | -$555,292 | |||||
| D | 2025-03-05 | MMSI | Merit Medical Systems Inc | Lloyd Brian G. | GC, Secretary | S - Sale+OE | $102.90 | -30,000 | 38,945 | -44% | -$3,087,000 | |||||
2025-03-04 | LMAT | Lemaitre Vascular Inc | Jasinski Lawrence J | Dir | S - Sale | $92.00 | -3,142 | 2,607 | -55% | -$289,064 | ||||||
2025-03-04 | STIM | Neuronetics, Inc. | Furlong Stephen | EVP, CFO, Treasurer | S - Sale | $4.48 | -1,867 | 610,053 | 0% | -$8,364 | ||||||
2025-03-04 | STIM | Neuronetics, Inc. | Macan William Andrew | EVP, GC, CCO, CS | S - Sale | $4.48 | -377 | 526,805 | 0% | -$1,689 | ||||||
2025-03-05 | OFIX | Orthofix Medical Inc. | Calafiore Massimo | Pres, CEO | P - Purchase | $17.43 | +9,914 | 222,404 | +5% | +$172,801 | ||||||
2025-03-05 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $25.29 | -472 | 172,743 | 0% | -$11,935 | ||||||
| D | 2025-03-04 | CERS | Cerus Corp | Jensen Chrystal | GC | S - Sale+OE | $1.58 | -66,292 | 405,198 | -14% | -$104,885 | |||||
| D | 2025-03-04 | CERS | Cerus Corp | Jayaraman Vivek K | COO | S - Sale+OE | $1.55 | -10,780 | 905,828 | -1% | -$16,693 | |||||
| D | 2025-03-04 | CERS | Cerus Corp | Greenman William Mariner | Pres, CEO | S - Sale+OE | $1.55 | -23,023 | 3,230,000 | -1% | -$35,651 | |||||
| DM | 2025-03-04 | CERS | Cerus Corp | Green Kevin Dennis | CFO | S - Sale+OE | $1.57 | -69,042 | 493,862 | -12% | -$108,658 | |||||
| DM | 2025-03-03 | CERS | Cerus Corp | Benjamin Richard J | Chief Medical Officer | S - Sale+OE | $1.57 | -57,546 | 394,373 | -13% | -$90,571 | |||||
| D | 2025-03-03 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale+OE | $287.43 | -600 | 66,539 | -1% | -$172,458 | |||||
2025-03-03 | PEN | Penumbra Inc | O'Rourke Bridget | Dir | S - Sale | $285.48 | -50 | 5,573 | -1% | -$14,274 | ||||||
2025-03-03 | PEN | Penumbra Inc | Bose Arani | Dir | S - Sale | $287.42 | -12,000 | 326,819 | -4% | -$3,448,993 | ||||||
| D | 2025-03-03 | PEN | Penumbra Inc | Yuen Maggie | CFO | S - Sale+OE | $286.00 | -2,000 | 16,143 | -11% | -$571,995 | |||||
| DM | 2025-03-03 | PEN | Penumbra Inc | Shiu Lambert | Chief Accounting Officer | S - Sale+OE | $285.73 | -7,789 | 33,269 | -19% | -$2,225,583 | |||||
| D | 2025-02-28 | MDXG | Mimedx Group, Inc. | Maersk-Moller Kimberly | Chief Commercial Officer | S - Sale+OE | $8.41 | -2,111 | 314,942 | -1% | -$17,743 | |||||
2025-03-03 | LUNG | Pulmonx Corp | Joshi Mehul | CFO, PAO | S - Sale | $7.12 | -14,384 | 221,986 | -6% | -$102,414 | ||||||
| D | 2025-03-03 | LUNG | Pulmonx Corp | Williamson Steven S. | Pres, CEO | S - Sale+OE | $7.14 | -27,689 | 376,038 | -7% | -$197,699 | |||||
2025-03-03 | LUNG | Pulmonx Corp | Lehman David Aaron | GC | S - Sale | $7.65 | -22,355 | 283,496 | -7% | -$170,921 | ||||||
2025-03-03 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $7.13 | -5,779 | 393,278 | -1% | -$41,193 | ||||||
2025-03-03 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale | $3.16 | -4,000 | 374,284 | -1% | -$12,639 | ||||||
2025-03-03 | INSP | Inspire Medical Systems, Inc. | Ban Randy | See Remarks | S - Sale | $185.84 | -3,947 | 7,592 | -34% | -$733,496 | ||||||
2025-03-03 | INSP | Inspire Medical Systems, Inc. | Rondoni John | CTO | S - Sale | $185.60 | -2,287 | 15,500 | -13% | -$424,467 | ||||||
| DM | 2025-03-03 | BSX | Boston Scientific Corp | Woodworth Emily | SVP, Global Controller, CAO | S - Sale+OE | $104.95 | -7,631 | 432 | -95% | -$800,897 | |||||
2025-03-05 | AORT | Artivion, Inc. | Semedo Anthony B. | Dir | P - Purchase | $25.31 | +2,100 | 36,259 | +6% | +$53,141 | ||||||
| D | 2025-02-28 | UFPT | Ufp Technologies Inc | Feldmann Cynthia L | Dir | S - Sale+OE | $230.72 | -2,756 | 4,049 | -40% | -$635,875 | |||||
| D | 2025-03-03 | MMSI | Merit Medical Systems Inc | Peterson Neil | COO | S - Sale+OE | $105.00 | -5,000 | 28,369 | -15% | -$525,000 | |||||
2025-03-03 | MMSI | Merit Medical Systems Inc | Evans Stephen C. | Dir | S - Sale | $105.31 | -5,000 | 4,657 | -52% | -$526,550 | ||||||
2025-03-03 | ATEC | Alphatec Holdings, Inc. | McGinnis Karen K | Dir | S - Sale | $12.26 | -38,320 | 57,541 | -40% | -$469,803 | ||||||
2025-03-04 | TMCI | Treace Medical Concepts, Inc. | Treace John T. | CEO, 10% | P - Purchase | $8.73 | +60,000 | 12,120,319 | 0% | +$524,064 | ||||||
| D | 2025-03-03 | RMD | Resmed Inc | Ghoshal Kaushik | Chief Commercial Officer, SaaS | S - Sale+OE | $235.40 | -9,113 | 9,725 | -48% | -$2,145,186 | |||||
2025-03-03 | RMD | Resmed Inc | Rider Michael J | Global GC | S - Sale | $234.10 | -64 | 8,910 | -1% | -$14,982 | ||||||
2025-02-28 | GMED | Globus Medical Inc | Rhoads Ann D | Dir | S - Sale | $78.68 | -7,500 | 35,384 | -17% | -$590,100 | ||||||
2025-03-03 | NVCR | Novocure Ltd | Weinberg Uri | Chief Innovation Officer | S - Sale | $18.92 | -268 | 166,243 | 0% | -$5,071 | ||||||
2025-03-03 | NVCR | Novocure Ltd | Leonard Frank X | EVP, Pres, Novocure Oncology | S - Sale | $18.54 | -2,527 | 143,673 | -2% | -$46,841 | ||||||
2025-03-03 | NVCR | Novocure Ltd | Cordova Ashley | CEO | S - Sale | $18.54 | -2,053 | 204,005 | -1% | -$38,055 | ||||||
2025-03-03 | NVCR | Novocure Ltd | Paravasthu Mukund | COO | S - Sale | $18.54 | -250 | 29,173 | -1% | -$4,634 | ||||||
2025-03-03 | IRTC | Irhythm Technologies, Inc. | Blackford Quentin S. | Pres, CEO | S - Sale | $108.77 | -8,145 | 208,741 | -4% | -$885,932 | ||||||
2025-03-03 | IRTC | Irhythm Technologies, Inc. | Rosenbaum Marc W. | Chief Accounting Officer | S - Sale | $108.77 | -314 | 11,507 | -3% | -$34,154 | ||||||
2025-03-03 | IRTC | Irhythm Technologies, Inc. | Smith Mervin | EVP Strategic Business Ops | S - Sale | $108.77 | -638 | 16,454 | -4% | -$69,395 | ||||||
2025-03-03 | IRTC | Irhythm Technologies, Inc. | Murphy Patrick Michael | CBO, CLO | S - Sale | $108.77 | -3,075 | 55,759 | -5% | -$334,468 | ||||||
2025-03-03 | IRTC | Irhythm Technologies, Inc. | Patterson Chad | Chief Commercial Officer | S - Sale | $108.77 | -2,756 | 58,440 | -5% | -$299,770 | ||||||
2025-03-03 | IRTC | Irhythm Technologies, Inc. | Shrishrimal Sumi | EVP, Chief Risk Officer | S - Sale | $108.77 | -1,726 | 36,117 | -5% | -$187,737 | ||||||
2025-03-03 | IRTC | Irhythm Technologies, Inc. | Turakhia Minang | EVP, CMO, CSO | S - Sale | $108.77 | -2,467 | 42,495 | -5% | -$268,336 | ||||||
2025-03-03 | IRTC | Irhythm Technologies, Inc. | Wilson Daniel G. | CFO | S - Sale | $108.77 | -2,341 | 45,307 | -5% | -$254,631 | ||||||
| A | 2025-02-28 | NVCR | Novocure Ltd | Weinberg Uri | Chief Innovation Officer | S - Sale | $18.75 | -4,637 | 166,511 | -3% | -$86,949 | |||||
| AM | 2025-02-27 | NVCR | Novocure Ltd | Cordova Ashley | CEO | S - Sale | $19.72 | -13,494 | 206,058 | -6% | -$266,126 | |||||
| AM | 2025-02-27 | NVCR | Novocure Ltd | Leonard Frank X | EVP, Pres, Novocure Oncology | S - Sale | $19.70 | -15,036 | 146,200 | -9% | -$296,257 | |||||
| A | 2025-02-27 | NVCR | Novocure Ltd | Puri Michal Nath | CHRO | S - Sale | $20.02 | -1,387 | 108,706 | -1% | -$27,773 | |||||
| A | 2025-02-27 | NVCR | Novocure Ltd | Leupin Nicolas | Chief Medical Officer | S - Sale | $20.02 | -991 | 50,133 | -2% | -$19,844 | |||||
| AM | 2025-02-27 | NVCR | Novocure Ltd | Paravasthu Mukund | COO | S - Sale | $19.71 | -2,014 | 29,423 | -6% | -$39,688 | |||||
| D | 2025-02-28 | MMSI | Merit Medical Systems Inc | Lloyd Brian G. | GC, Secretary | S - Sale+OE | $99.50 | -25,000 | 38,993 | -39% | -$2,487,500 | |||||
| D | 2025-02-28 | MMSI | Merit Medical Systems Inc | Voigt Michel James | CHRO | S - Sale+OE | $99.68 | -13,809 | 22,414 | -38% | -$1,376,481 | |||||
| D | 2025-02-28 | MMSI | Merit Medical Systems Inc | Parra Raul Jr. | CFO, Treasurer | S - Sale+OE | $98.81 | -12,451 | 26,971 | -32% | -$1,230,283 | |||||
2025-02-27 | UFPT | Ufp Technologies Inc | Croteau Daniel C | Dir | S - Sale | $228.41 | -6,846 | 1,785 | -79% | -$1,563,724 | ||||||
2025-02-28 | NVCR | Novocure Ltd | Weinberg Uri | Chief Innovation Officer | S - Sale | $18.75 | -4,637 | 166,511 | -3% | -$86,949 | ||||||
2025-02-27 | NVCR | Novocure Ltd | Leupin Nicolas | Chief Medical Officer | S - Sale | $20.02 | -991 | 50,133 | -2% | -$19,844 | ||||||
2025-02-27 | NVCR | Novocure Ltd | Puri Michal Nath | CHRO | S - Sale | $20.02 | -1,387 | 108,706 | -1% | -$27,773 | ||||||
| M | 2025-02-27 | NVCR | Novocure Ltd | Leonard Frank X | EVP, Pres, Novocure Oncology | S - Sale | $19.70 | -15,036 | 146,200 | -9% | -$296,257 | |||||
| M | 2025-02-27 | NVCR | Novocure Ltd | Cordova Ashley | CEO | S - Sale | $19.72 | -13,494 | 206,058 | -6% | -$266,126 | |||||
| M | 2025-02-27 | NVCR | Novocure Ltd | Paravasthu Mukund | COO | S - Sale | $19.71 | -2,014 | 29,423 | -6% | -$39,688 | |||||
| D | 2025-02-28 | BSX | Boston Scientific Corp | Woodworth Emily | SVP, Global Controller, CAO | S - Sale+OE | $101.13 | -9,887 | 2,114 | -82% | -$999,872 | |||||
| A | 2024-08-13 | APYX | Apyx Medical Corp | Hill Matthew C | CFO | P - Purchase | $1.13 | +6,000 | 8,500 | +240% | +$6,780 | |||||
2025-02-27 | OSUR | Orasure Technologies Inc | Gagliano Nancy J | Dir | P - Purchase | $3.08 | +12,750 | 91,524 | +16% | +$39,270 | ||||||
2025-02-28 | OSUR | Orasure Technologies Inc | Eglinton Manner Carrie | Pres, CEO | P - Purchase | $3.49 | +28,670 | 1,288,334 | +2% | +$100,027 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |